119MO Phase I/II trial evaluating the innovative therapeutic cancer vaccine PDClung01 in combination with anti-PD-1 in patients (pts) with untreated stage IV non-small cell lung ca... by Vansteenkiste, J.F., Cuppens, K., Demedts, I., Borm, F., Biesma, B., Pérol, M., Theelen, W., Wauters, E., Colinet, B., Van Kerckhove, C., Buchmeier, E.L., Althoff, F.C., Pons-Tostivint, E., Derijcke, S., Moro-Sibilot, D., Sibille, A., Plumas, J., Adriaenssens, S., Cantero, F., Skrzypski, M.

Get full text

202P The therapeutic cancer vaccine PDClung01 induces immune responses with or without anti-PD-1 treatment in patients with non-small cell lung cancer by Sibille, A., Plumas, J., Demedts, I., Pons-Tostivint, E., Van De Kerkhove, C., Derijcke, S., Collodoro, M., Al Badawy, K., Duchayne, C., Debruyne, C., Pérol, M., Buchmeier, E.L., Cuppens, K., Vansteenkiste, J.F.

Get full text